-
[show abstract]
[hide abstract]
ABSTRACT: To assess the safety and efficacy of a stock alloplastic total temporomandibular joint (TMJ) implant system, the Biomet Microfixation TMJ Replacement System.
During a 10-year multicenter clinical trial from 1995 to 2005, 442 Biomet Microfixation TMJ Replacement Systems were implanted in 288 patients (154 bilaterally and 134 unilaterally). Patients were followed at landmark times, including the date of surgery and at 1 month, 3 months, 1 year, 1 year 6 months, and 3 years. The 3 major metrics that were evaluated were preoperative and postoperative pain, interference with eating, and maximal incisal opening. Paired t tests and comparison analyses were used to assess outcomes.
There was statistically significant improvement in pain level (P = .0001), jaw function (P = .0001), and incisal opening (P = .0001). Although there were complications necessitating the removal of 14 of 442 implants (3.2%), there were no device-related mechanical failures.
The clinical study presented supports the conclusion that a stock TMJ alloplastic replacement, based on sound orthopedic and biomedical principles, is a safe and efficacious option when alloplastic reconstruction of the TMJ is indicated.
Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons 04/2012; 70(4):787-94; discussion 795-6. · 1.58 Impact Factor
-
Atlas of the oral and maxillofacial surgery clinics of North America 09/2011; 19(2):221-32.
-
Peter D Quinn
American journal of orthodontics and dentofacial orthopedics: official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 11/2010; 138(5):533-4; author reply 534. · 1.33 Impact Factor
-
Head and Neck Pathology 12/2009; 3(4):283-5.
-
Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons 06/2009; 67(5):937-42. · 1.58 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The temporomandibular joint (TMJ) has many essential functions. None of its components are exempt from injury. Facial asymmetry, malocclusion, disturbances in growth, osteoarthritis, and ankylosis can manifest as complications from trauma to the TMJ. The goals of initial treatment include achievement of pretraumatic function, restoration of facial symmetry, and resolution of pain. These same objectives hold true for late repairs and reconstruction of the TMJ apparatus. Treatment is demanding, and with opposing approaches. The following article explores various treatment options for problems presenting as a result of a history of trauma to the TMJ.
Craniomaxillofacial Trauma and Reconstruction 05/2009; 2(2):91-101.
-
[show abstract]
[hide abstract]
ABSTRACT: We report a patient with Schimmelpenning syndrome with two previously unreported oral manifestations: multiple pigmented malformed teeth and an adenomatoid odontogenic tumor of the anterior mandible. Also found were multiple complex odontomas, bilateral maxillary fibro-osseous lesions and recurrent central giant cell granulomas of the jaws.
American Journal of Medical Genetics Part A 05/2007; 143A(8):881-3. · 2.39 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Surgical intervention is appropriate in a small percentage of patients with temporomandibular joint disorders when it is based on a specific diagnosis of intracapsular pathology not amenable to nonsurgical modalities. Expected advances in our understanding of the complex molecular, biochemical, and genetic factors that influence these disease states clearly will allow less invasive techniques and even obviate the need for some open arthroplastic interventions altogether in the future. In the meantime, reasonable, well-intentioned surgeons must rely on the current body of surgical knowledge to use surgery as judiciously as possible.
Oral and Maxillofacial Surgery Clinics of North America 09/2006; 18(3):411-7, vii. · 0.76 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The classical treatment for temporomandibular joint (TMJ) ankylosis in children: 1) joint release; 2) arthroplasty; 3) reconstruction; and 4) postoperative physical therapy (PT), is often unsuccessful. Postoperative physical therapy is difficult in the young patient due to poor cooperation. Moreover, there is a subgroup of patients who have a refractory congenital proliferative bony process that is the cause of their disease. In these patients, a role for distraction osteogenesis (DO) has been defined. We present a series of young patients with congenital proliferative TMJ ankylosis. Some have failed classic treatment. In such cases, DO is used to expand the mandibular size and soft tissue matrix. This creates a static open bite, facilitates mid-facial growth, and avoids compromise of the airway, speech, nutrition, and oral hygiene. To maintain these objectives, mandibular DO may be repeated as the child matures. Once skeletal maturity is reached, DO is used to normalize occlusion and further expand the soft tissue envelope prior to definitive reconstruction and aggressive post-op PT. In seven patients, this protocol has been used. Five patients are currently in the active phase of growth and undergoing interim treatment with mandibular DO. Two patients have reached skeletal maturity and have completed the protocol of DO with definitive arthroplasty and reconstruction. DO is a valuable aid in the treatment of the problematic child with congenital proliferative TMJ ankylosis. Interim DO, prior to definitive arthroplasty and reconstruction, can provide a static open bite that prevents progressive deformity and its associated functional disturbances.
Journal of Craniofacial Surgery 06/2006; 17(3):605-10. · 0.82 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Traditionally, the majority of oral and maxillofacial surgery patients are young and healthy. With the ever-expanding scope of the specialty, however, more surgically extensive procedures increasingly are being performed on more medically complex patients. To optimize comprehensive patient care, oral and maxillofacial surgeons are obligated to possess a firm knowledge of the basic principles of fluid management and use a sound strategy for blood product usage.
Oral and Maxillofacial Surgery Clinics of North America 03/2006; 18(1):7-17, v. · 0.76 Impact Factor
-
Journal of Oral and Maxillofacial Surgery 03/2004; 62(2):240-3. · 1.64 Impact Factor
-
Journal of Oral and Maxillofacial Surgery 06/2003; 61(5):626-31. · 1.64 Impact Factor
